When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there’s not enough time to set off the cell’s alarm system.
Now, a Loyola University Chicago study has discovered the protein that helps the virus travel so fast. Researchers found that without this protein, the virus became stranded in the cytoplasm, where it was detected by the viral defense system. (The cytoplasm is the portion of the cell outside the nucleus.)
“By preventing its normal movement, we essentially turned HIV-1 into a sitting duck for cellular sensors,” said Edward M. Campbell, PhD, corresponding author of the study, published in the Proceedings of the National Academy of Sciences. Campbell is an associate professor in the Department of Microbiology and Immunology of Loyola University Chicago Stritch School of Medicine.
HIV-1 infects and kills immune system cells, including T cells and macrophages that were used in the study. This cripples the immune system, making the patient vulnerable to common bacteria, viruses and other pathogens that are usually harmless in people with healthy immune systems.
After HIV-1 enters a cell, it has to work its way through the cytoplasm to the nucleus. Once inside the nucleus, HIV-1 takes control of the cell and makes additional HIV-1 copies. But getting through the cytoplasm is not easy. Cytoplasm consists of fluid that is thick with proteins and structures such as mitochondria. “Something the size of a virus cannot just diffuse through the cytoplasm,” Campbell said. “It would be like trying to float to the bathroom in a very crowded bar. You need to have a plan.”
HIV-1 is able to get to the nucleus quickly via tubular tracks called microtubules. The virus attaches itself to a molecular motor called dynein, which moves down the microtubule like a train car on tracks.
Campbell and colleagues discovered the “ticket” HIV-1 needs to get on the train — a protein called bicaudal D2. HIV-1 binds to bicaudal D2, which recruits the dynein molecular motor. The dynein then transports HIV-1 towards the nucleus.
The finding raises the possibility of developing a drug that would prevent HIV-1 from binding to bicaudal D2, thus stranding the virus in the cytoplasm. This would not only prevent infection, but also give the cell time to turn on antiviral genes that would protect it and neighboring cells from infection.
Learn more: Study suggests a way to stop HIV in its tracks
The Latest on: HIV
- Potential HIV breakthrough could also play a role in battling COVID-19on March 2, 2021 at 8:27 pm
Scientists have identified a group of people who, even though infected, show no viral level of HIV. Now they hope to harness the virus fighting ability and transform it into a better therapy and ...
- Abbott Announces HIV Vaccine Research Findings: 'Another Step Toward Unlocking A Cure'on March 2, 2021 at 5:40 pm
Abbott Laboratories (NYSE: ABT) has announced a potential research breakthrough that could lead to advancements and potential vaccines for the treatment of HIV. What Happened: Abbott’s researchers ...
- African study triggers HIV vaccine hopeson March 2, 2021 at 1:27 pm
The discovery of a rare group of people with controlled HIV in Africa could lead to new treatments, including a vaccine to eliminate the virus.
- Creator of HIV drama 'It's a Sin' on opening old wounds, prioritizing gay actorson March 2, 2021 at 1:01 pm
Russell T. Davies said he pulled stories from his own life to portray the pain, joy and uncertainty of being young and gay in the '80s amid the backdrop of AIDS.
- HIV findings in DR Congo 'give hope for cure'on March 2, 2021 at 11:27 am
The discovery of a large group of people who control HIV without taking medication is leading to hopes of an eventual cure, scientists say. The study found as many as 4% of HIV carriers in the ...
- DR Congo HIV study: ‘New hope in search for cure’on March 2, 2021 at 10:03 am
Scientists carrying out HIV research in the Democratic Republic of Congo have discovered a rare group of people who could potentially unlock new treatments to tackle the virus. Known as HIV ...
- Scientists find 'HIV elite controllers' living in Congo, possibly paving way for vaccine, cureon March 2, 2021 at 9:10 am
Scientists have claimed to discover a rare group of people in the Democratic Republic of Congo who have tested positive for HIV antibodies but are living with low to non-detectable levels of viral ...
- Efficacy and safety of human papillomavirus vaccination in HIV-infected patients: a systematic review and meta-analysis | Scientific Reportson March 2, 2021 at 8:04 am
We performed a systematic review of RCTs to assess HPV vaccines efficacy and safety on HIV-infected people compared to placebo or no intervention in terms of seroconversion, infections, neoplasms, ...
- Korber's Epigraph algorithm used for HIV, Ebola, Marburg thus far (image)on March 2, 2021 at 6:07 am
Since 2010, more than 460 swine-flu variant infections have been reported in humans in the United States. Pigs are susceptible to swine, avian, and human influenza viruses, making them the perfect ...
- Sec24C is an HIV-1 host dependency factor crucial for virus replicationon March 1, 2021 at 10:54 am
Virus–host interactions are identified during HIV-1 trafficking in cellular compartments that are crucial for productive infection of cells.
via Google News and Bing News